134 related articles for article (PubMed ID: 14635095)
1. Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for delta opioid receptors.
Choi H; Murray TF; Aldrich JV
Biopolymers; 2003; 71(5):552-7. PubMed ID: 14635095
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors.
Maeda DY; Ishmael JE; Murray TF; Aldrich JV
J Med Chem; 2000 Oct; 43(21):3941-8. PubMed ID: 11052799
[TBL] [Abstract][Full Text] [Related]
3. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
4. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of potential affinity labels derived from endomorphin-2.
Choi H; Murray TF; Aldrich JV
J Pept Res; 2003 Feb; 61(2):58-62. PubMed ID: 12492899
[TBL] [Abstract][Full Text] [Related]
6. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
Szatmári I; Orosz G; Medzihradszky K; Borsodi A
Biochem Biophys Res Commun; 1999 Nov; 265(2):513-9. PubMed ID: 10558900
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
9. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
Vig BS; Zheng MQ; Murray TF; Aldrich JV
J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
[TBL] [Abstract][Full Text] [Related]
10. Binding properties of C-truncated delta opioid receptors.
Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917
[TBL] [Abstract][Full Text] [Related]
11. Dermorphin-based potential affinity labels for mu-opioid receptors.
Choi H; Murray TF; Aldrich JV
J Pept Res; 2003 Jan; 61(1):40-5. PubMed ID: 12472847
[TBL] [Abstract][Full Text] [Related]
12. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
13. An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I.
Aldrich JV; Choi H; Murray TF
J Pept Res; 2004 Feb; 63(2):108-15. PubMed ID: 15009532
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.
Maeda DY; Berman F; Murray TF; Aldrich JV
J Med Chem; 2000 Dec; 43(26):5044-9. PubMed ID: 11150176
[TBL] [Abstract][Full Text] [Related]
15. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
16. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
[TBL] [Abstract][Full Text] [Related]
19. Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptor.
McFadyen IJ; Sobczyk-Kojiro K; Schaefer MJ; Ho JC; Omnaas JR; Mosberg HI; Traynor JR
J Pharmacol Exp Ther; 2000 Dec; 295(3):960-6. PubMed ID: 11082429
[TBL] [Abstract][Full Text] [Related]
20. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
